Leinco T

Leinco Technologies is a biotechnology company founded in 1992 that specializes in the research, development, and manufacturing of high-quality antibodies and recombinant proteins. The company provides an extensive product catalog, including monoclonal and polyclonal antibodies, ELISA kits, and various reagents for applications such as flow cytometry, immunohistochemistry, and western blotting. Beyond its catalog products, Leinco operates as a contract development and manufacturing organization (CDMO), offering tailored services that range from antigen design and gene synthesis to stable cell line generation, protein expression, and custom antibody engineering. Their manufacturing facility in Fenton, Missouri, is ISO 9001:2015 certified, supporting both small-scale research needs and large-scale production requirements.

These products and services serve as essential tools for scientists in life sciences discovery, diagnostics, and biopharmaceutical development. By focusing on high-purity, low-cross-reactivity products—such as their functional grade antibodies for in vivo studies and biosimilars for therapeutic research—Leinco enables researchers to generate reproducible and reliable data. The company acts as a collaborative partner for laboratories and biopharma firms, utilizing consultative expertise to help clients navigate the complexities of antibody development and protein production, ultimately accelerating the path from early discovery to clinical diagnostics and therapeutic applications.